Discovery and Optimization of Imidazothiazole Carboxamides as Novel Anti-Tuberculosis Agents
Meng, L.; Grant, D.; Xie, H.; Ford, R.; Webb, J.; McNamara, C. W.; Sukheja, P.; Yang, B.; Chatterjee, A. K.
Show abstract
Screening of the open-access CRESTdb small-molecule library identified the imidazothiazole carboxamide sCQG200 (1) as an initial hit, with activity against H37Rv and Erdman Mycobacterium tuberculosis strains in cholesterol-containing medium (MIC90= 6.88 uM and 4.48 uM, respectively) and against intracellular Mtb (EC50= 3.80 uM). sCQG200 retained activity against drug-resistant Mtb strains, including clinical MDR/XDR isolates. SAR optimization led to analogs 21 and 24 with substantially improved antimycobacterial potency. Mouse pharmacokinetic studies following oral and intravenous administration showed 62.1% and 29.5% oral bioavailability for 21 and 24, respectively. This structurally differentiated chemotype provides a promising starting point for further optimization as antitubercular agent.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Nitroimidazopyrazinones with oral activity against tuberculosis and Chagas disease in mouse models of infection 95%
- Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for SARS-CoV-2 3CL Protease 94%
- CRCM5484: A BET- BDII Selective Compound With Differential Anti-Leukemic Drug Modulation 94%
Similar papers in this journal
- Identification of new MmpL3 inhibitors by untargeted and targeted mutant screens defines MmpL3 domains with differential resistance 95%
- Lead optimisation of dehydroemetine for repositioned use in malaria 94%
- New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the In Vitro Activity of β-Lactam Antibiotics Against Mycobacterium abscessus Complex Clinical Isolates 93%
Similar papers in this journal
- Legacy 4(1H)-quinolone scaffolds activity against acute and chronic Toxoplasma gondii infection 96%
- Identification of α-azacyclic acetamide-based inhibitors of P. falciparum Na+ pump (PfATP4) with fast-killing asexual blood-stage antimalarial activity by phenotypic screening 95%
- High-throughput screening of more than 30,000 compounds for anthelmintics against gastrointestinal nematode parasites 94%
Similar papers in this journal
- A Platinum Butterfly Effect: Small Changes Turn an Anticancer Drug into a Non-toxic Metalloantibiotic with In Vivo Efficacy 94%
- Small-molecule screen in C. elegans identifies benzenesulfonamides as inhibitors of microsporidia spores 90%
- Genome wide analyses reveal the role of mutator phenotypes in the emergence of drug resistance in Mycobacterium tuberculosis 87%
Similar papers in this journal
- Treatment outcomes of bedaquiline-resistant tuberculosis: a retrospective and matched cohort study 86%
- Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV) 86%
- Sensitivity of novel SARS-CoV-2 Omicron subvariants, BA.2.11, BA.2.12.1, BA.4 and BA.5 to therapeutic monoclonal antibodies 84%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.